Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.

@article{Sterne2020AssociationBA,
  title={Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.},
  author={J. Sterne and S. Murthy and J. Diaz and Arthur S Slutsky and Jes{\'u}s Villar and D. C. Angus and D. Annane and L. Azevedo and O. Berwanger and A. Cavalcanti and P. Dequin and Bin Du and J. Emberson and D. Fisher and B. Giraudeau and A. Gordon and Anders Granholm and C. Green and R. Haynes and N. Heming and J. Higgins and P. Horby and P. J{\"u}ni and M. Landray and A. Le Gouge and M. Leclerc and W. Lim and F. R. Machado and C. Mcarthur and F. Meziani and M. M{\o}ller and A. Perner and Marie Warrer Petersen and J. Savovi{\'c} and B. Tomazini and V. Veiga and S. Webb and J. Marshall},
  journal={JAMA},
  year={2020}
}
  • J. Sterne, S. Murthy, +35 authors J. Marshall
  • Published 2020
  • Medicine
  • JAMA
  • Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced mortality in hospitalized patients with COVID-19 who required respiratory support. Objective To estimate the association between administration of corticosteroids compared with usual care or placebo and 28-day all-cause mortality. Design, Setting, and Participants Prospective meta-analysis that pooled data from 7… CONTINUE READING
    Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19
    A living WHO guideline on drugs for covid-19
    • 9
    • PDF